The aim of this human intervention study was to evaluate the D9-desaturation of trans-11-18 : 1 (trans-vaccenic acid; tVA) to cis-9,trans-11-18 : 2 (c9,t11 conjugated linoleic acid; CLA) and of trans-12-18 : 1 (t12) to cis-9,trans-12-18 : 2 after a short-term (7 d) and a long-term (42 d) supplementation period. The conversion rates of both trans-18 : 1 isomers were estimated by lipid analysis of serum and red blood cell membranes (RBCM). Subjects started with a 2-week adaptation period without supplements. During the 42 d intervention period, the diet of the test group was supplemented with 3 g/d of tVA and 3 g/d of t12. The diet of the control group was supplemented with a control oil. Serum tVA and t12 levels in the test group increased by fivefold and ninefold after 7 d, respectively, and by eight-and 12-fold after 42 d, respectively, when compared with the adaptation period (P#0·002). The serum c9,t11 CLA levels increased by 1·7-and 2·0-fold after 7 d and 42 d, respectively (P#0·001). After 42 d, the test group's RBCM c9,t11 CLA content was elevated by 20 % (P¼ 0·021), whereas in the control group it was decreased by 50 % (P¼ 0·002). The conversion rate of tVA was estimated at 24 % by serum and 19 % by RBCM. No increase in c9,t12-18 : 2 was observed in the serum and RBCM, and thus no conversion of t12 could be determined. In conclusion, the endogenous conversion of dietary tVA to c9,t11 CLA contributes approximately one quarter to the human CLA pool and should be considered when determining the CLA supply.
Trans-vaccenic acid (trans-11-18 : 1; tVA) is the predominant trans monoen in ruminant fats (30 -80 % of total trans-18 : 1 isomers; Aro et al. 1998; Precht et al. 2001 ; unpublished data), depending on the cattle feeding regime (Jahreis et al. 1997; Bauman & Griinari, 2003; Kraft et al. 2003) . In partially hydrogenated vegetable oils, tVA ranges between 13 % and 22 % of total trans-18 : 1 fatty acid (Molkentin & Precht, 1995; Aro et al. 1998; Wolff et al. 2000) . The content of trans-12-18 : 1 (t12) is similar in both and ranges from 4 % to 13 % of total trans-18 : 1 (Kraft et al. 2003; European Food Safety Authority, 2004) .
tVA is formed during the biohydrogenation of several PUFA (e.g. c9,c12-18 : 2) by rumen bacteria (Noble et al. 1974) . In this process, numerous geometric and positional isomers of conjugated linoleic acid (CLA) are created as further intermediates, but cis-9,trans-11-18 : 2 (c9,t11 CLA) is predominantly formed (Kepler et al. 1966; Griinari & Bauman, 1999) . The endogenous desaturation of both tVA to c9,t11 CLA and t12 to c9,t12-18 : 2 is catalysed by stearoylCoA desaturase (E 1.14.99.5), also commonly known as D9-desaturase (Pollard et al. 1980; Holman & Mahfouz, 1981; Griinari et al. 2000) . In cows, the endogenous synthesis of c9,t11 CLA from tVA occurs mainly in the mammary gland and accounts for the main source of c9,t11 CLA in the milk and tissues (Griinari et al. 2000; Corl et al. 2001; Piperova et al. 2002) . The conversion of t12 to c9,t12-18 : 2 in humans is still, however, unknown.
Several studies have provided evidence for the endogenous synthesis of CLA via D9-desaturase in non-ruminant animals (Ip et al. 1999; Gläser et al. 2000; Santora et al. 2000; Banni et al. 2001; Loor et al. 2002; Kraft, 2004) , as well as in man (Salminen et al. 1998; Adlof et al. 2000; Turpeinen et al. 2002) . The enrichment of CLA in body tissues via the endogenous conversion of tVA was associated with anticarcinogenic effects in animals (Ip et al. 1999; Banni et al. 2001; Corl et al. 2003; Lock et al. 2004) . These researchers and others have postulated potential effects for CLA, and these concepts have been reviewed in Belury (2002) , Parodi (2004) and Lee et al. (2005) . Wolff (1995) reported dietary intake levels of 1·3 -1·8 g/d of total trans-18 : 1 from ruminant fats for people from countries of the European Economic Community (except Spain and Portugal). Thus, the daily intake of tVA in the most European countries probably exceeds 0·7 -1·0 g/d, whereas the CLA dietary intake is lower, ranging between 300 and 500 mg/d (Fritsche & Steinhart, 1998; Aro et al. 2000; Fremann et al. 2002; Jahreis & Kraft, 2002; Voorrips et al. 2002) . At present, insufficient data are available concerning the isomeric distribution of trans-18 :1 in different food sources, and the human dietary intake of these individual isomers is generally unknown.
The aim of the present human intervention study was to evaluate the endogenous D9-desaturation of both tVA (3·0 g/d) to c9,t11 CLA, and t12 (3·0 g/d) to c9,t12-18 : 2, after a short-term (7 d) and a long-term (42 d) supplementation period. The conversion rates of the two trans-18 : 1 isomers were estimated by lipid analysis of serum and red blood cell membranes (RBCM).
Subjects and methods

Subjects
Volunteers were recruited by advertisement. The volunteers were selected after confirming that they were healthy, had a BMI of over 18 kg/m 2 and less than 30 kg/m 2 , had no diagnosed diseases, were not taking any medications (except contraceptives), were not vegetarians or vegans, were not abuser of alcohol and were taking no dietary supplements. Women and men fitting these criteria were informed of the purpose, course and possible risks of the study. All volunteers completed a questionnaire on health, lifestyle and dietary factors (e.g. consumption of dairy products) before entering the study. All subjects gave their written informed consent before participating. The study protocol was approved by the Ethical Committee of the Friedrich Schiller University of Jena. Body fat measurements were performed using a 50 kHz-frequency impedance analyser (Data Input GmbH, Darmstadt, Germany) with phase-sensitive technology. Bioelectrical impedance assessment and body weight were recorded at the beginning of the study and at the end of each study period.
The age of the volunteers ranged from 20 to 28 years (mean 24 (SD 3 years), and the BMI were between 19 and 26 kg/m 2 (mean 21 (SD 2) kg/m 2 ). Two subjects were smokers (, ten cigarettes/d), and all the women were taking oral contraceptives. The subjects were normocholesterolaemic (mean 4·4 (SD 0·7) mmol/l) and had an LDL-cholesterol:HDL-cholesterol ratio of less than 3 and a triacylglycerol (TAG) concentration of 1·0 (SD 0·4) mmol/l (Table 1) .
Study design and diets
The study consisted of a 2-week adaptation period and a 6-week intervention period. Throughout the complete study (8 weeks), the volunteers had to consume a ruminant-fat-free baseline diet. During this time, the volunteers consumed their habitual diet but without ruminant-related products (meat, meat products, milk, dairy products), thus minimizing their intake of CLA and trans-fatty acids. They were instructed to substitute the staples of soya milk for milk, margarine for butter, vegetable coffee whitener for cream, vegetable spreads for cheese, etc. in their habitual diet. In addition, the subjects received recipes to prepare ruminantfat-free meals, cakes, etc. to comply with the baseline diet.
At the end of each study period, the volunteers consumed a standardized ruminant-fat-free diet over the last 7 d (Fig. 1) . During the standardized diet, the volunteers received fresh food every day and were instructed to consume only the provided food. All components of the diet were identical for each participant and were consumed to their individual requirements.
After the adaptation period, the subjects were randomly allotted to two groups (twelve per group). As a criterion for selecting subjects, the number of men and women was balanced in each study group: six men and six women. Before the intervention study was started, the characteristics of the two treatment groups, for example anthropometric data, LDLcholesterol:HDL-cholesterol ratio, TAG concentration and total cholesterol, were compared to confirm optimal study group selection (Table 1 ). The diet of the test group was supplemented with 3·0 g/d of tVA and 3·0 g/d of t12. The control group diet was supplemented with a control oil to make the diets of the two treatment groups isocaloric (Fig. 1) .
A commercially prepared mixture of fatty acids (Natural ASA, Hovdebygda, Norway) was used for this study because of its availability and reasonable costs. This trans-isomer mixture comprised mainly tVA and t12 (1-1), and these two components constituted over 60 % of the total fatty acids in the preparation. In addition, the trans-isomer mixture contained approximately 20 % total fatty acids of c11-18 : 1 and c12-18 : 1 in equal shares as technical byproducts. This transisomer mixture was applied as a TAG. The control oil was a mixture of palm kernel oil and rapeseed oil in the ratio 1:1, which possesses a fatty acid distribution similar to that found in the common Western diet without trans-fatty acids and CLA.
Both experimental fats (trans-isomer mixture and control oil) were added to a commercially available chocolate spread (with c9 -18 : 1 as its predominate fatty acid) to make the supplements palatable to the volunteers. During the adaptation period, the volunteers consumed 20 g/d of the pure chocolate spread. In the intervention period, both groups consumed daily 20 g of the experimental fat/chocolate spread mixture (with control oil or trans-isomer mixture, depending on the group).
Before starting the study, the energy requirements of the each individual subject were determined by recording the total individual dietary intake for a 7 d period. Standardized diet food supplies were provided to meet the individual subject's requirements. The data provided by the 7 d food intake record were analysed using the PRODI 4.4 expert software package (Nutri-Science GmbH, Freiburg, Germany). During the time the standardized was consumed, the residues and non-comestibles (e. g. banana peel) of the provided food were returned and weighed each day, thus allowing for more accurate determinations of food consumption. Duplicate portions of the dietary supplies were collected, homogenized and sampled to allow for nutritional analysis of the study diet. The homogenized samples were freeze-dried, and DM, total fat and N content were determined according to the methods of the Association of Official Analytical Chemists (1995). The total dietary fibre content was analysed by an enzymatic test kit (BIOQUANT; Merck, Darmstadt, Germany). The total digestible carbohydrates were calculated as the difference between the DM and the sum of protein, fat and dietary fibre.
Blood collection
Blood samples were collected after 7 d of the standardized diet had been consumed for both the adaptation (0 d) and intervention (42 d) periods. In addition, blood was collected on day 7 of the intervention period ( Fig. 1) .
After an overnight fast, blood was collected between 07.30 and 08.30 hours by venepuncture into Vacutainers for serum preparation. Red blood cells (RBC) were isolated from blood collected into Vacutainer (BD Vacutainer Systems, Heidelberg, Germany) tubes with EDTA as an anticoagulant. After the plasma and platelets had been removed (15 min, 1000 g), the RBC were dispersed in PBS (0·9 %) and washed three times by centrifugation (20 min, 1000 g). After freezing at 2 808C, membrane preparations were washed two or three times in PBS (0·9 %) until the supernatant was clear in order to remove haemoglobin and other cytoplasmic components.
Cholesterol determination
Serum total cholesterol, HDL-cholesterol, LDL-cholesterol and TAG concentration were ascertained by enzymatic methods using the autoanalyser Synchron LX system (Beckman Coulter, Fullerton, USA).
Lipid analysis
The lipid contents of serum, RBCM and food samples were extracted with chloroform-methanol -water (2:1:1, v/v/v) according to Folch et al. (1957) . The lipid extracts of RBCM and food were concentrated and treated with NaOCH 3 (0·5 M NaOCH 3 in methanol, 15 min, 608C) to produce fatty acid methyl esters (FAME) extracts. FAME of serum lipids were prepared by using a combination of NaOCH 3 and 1,1,3,3-tetramethylguanidine (Sigma-Aldrich, St Louis, USA; 1,1,3,3-tetramethylguanidine in dry methanol, 1:4, v/v, 5 min, 1008C). All FAME extracts were purified by TLC. The analysis of sample FAME extracts was conducted via GC (GC-17 V3; Shimadzu, Tokyo, Japan) equipped with an autosampler and a flame ionization detector.
Two different GC procedures were required to analyse the FAME distribution of these samples. The first method determined the identity and general fatty acid distribution of fatty acids ranging from four to twenty-five carbon atoms in length, including total CLA, using a fused-silica capillary column DB-225 ms (60 m £ 0·25 mm internal diameter, film thickness 0·25 mm; J&W Scientific, Folsom, USA). The second GC method separates the cis and trans isomers of 18 : 1 fatty acid using a fused-silica capillary column CPselect (200 m £ 0·25 mm internal diameter, film thickness 0·25-mm; Varian, Middelburg, The Netherlands). In the first GC analysis, c9,t11 CLA co-eluted with two minor CLA isomers (t8,c10 and t7,c9). The final stage of the FAME analysis was a determination of the distribution of CLA isomers by Ag þ HPLC (LC10A; Shimadzu). The exact details of the methodologies have been published in Kraft et al. (2003) . The proportions of separated fatty acid from the lipids in the food, serum and RBCM are expressed as mg/g of total FAME.
Estimation of the conversion rate
The conversion rate of tVA to c9,t11 CLA was estimated according to Turpeinen et al. (2002) . The individual conversion rate of serum tVA for each test-group subject was estimated by the net change in c9,t11 CLA level (Dc9,t11 CLA) compared the sum of the net change in tVA level (DtVA) and Following this, the term DtVA was the proportion of tVA that was not converted and Dc9,t11 CLA was the proportion of converted tVA, on condition that the subjects received a diet free of CLA and tVA. In addition, the slope of the linear regression of Dc9,t11 CLA v. the sum of DtVA and Dc9,t11 CLA represents the mean conversion (Turpeinen et al. 2002) . The conversion rate of t12 to c9,t12-18 : 2 was estimated in the same manner.
Statistical analysis
All statistical analysis were performed using SPSS version 11·5 (SPSS Inc., Chicago, IL, USA) with P, 0·05 taken to indicate significant intra-and intergroup changes. The results are stated as means and standard deviations. Possible differences between the different groups after intervention were analysed with the non-parametric Mann -Whitney Utest. Differences between the adaptation period and the intervention period within the treatment groups were analysed with the Wilcoxon test. Correlations were calculated using Pearson's correlation analysis.
Results
Diet
All participants tolerated the experimental fats well. Subjects showed no change in anthropometric data (body weight, BMI, fat mass, etc.) during the study. The intake in both treatment groups of DM, carbohydrates, protein and dietary fibre during the adaptation and intervention period did not significantly differ ( Table 2 ). The total fat intake of both treatment groups increased after supplementation with the experimental fat. In general, women in both treatment groups showed a lower food intake than men, but the fatty acid composition of their diet did not differ ( Table 2 ). The dietary fatty acid composition of the control group during the intervention was identical to that seen in both study groups in the adaptation period. The fatty acid composition of the test-group diet contained both supplemented trans isomers (, 8 % of fat intake), which replaced similar proportions of c9-18 : 1 and c9,c12-18 : 2 fatty acids compared with the adaptation diet ( Table  2) . No difference in total C18 fatty acid intake was observed between the control group and the test group. The standardized diet contained only marginal amounts of trans-fatty acids and CLA, as planned (Table 2) .
Serum
Despite the fact that blood samples collected after 7 d of the intervention period from the test group were not associated with the standardized diet, the serum fatty acid distribution of these samples showed no significant differences when compared with samples from the test group after 42 d of intervention, with the exception of tVA and t12 levels ( Table 3) . The fatty acid distribution of serum lipids did not differ between the men and women in both study groups. No significant differences in total serum C18 fatty acid level were detected between the two study groups, and their total serum C18 fatty acid levels were comparable with those seen during the adaptation period (Table 3) . The tVA serum level of the test group increased by fivefold and eightfold, whereas the t12 serum level increased by ninefold and 12-fold, after 7 d and 42 d of intervention, respectively, compared with the adaptation period (P# 0·002). The serum c9,t11 CLA level of the test group increased by the 1·7-and 2·0-fold after 7 d and 42 d of intervention, respectively, compared with the adaptation period (P # 0·001). The concentration of serum c9,t12-18 : 2 remained unchanged in the test group samples. The increase in tVA and t12 levels after 7 d of trans-isomer mixture supplementation (DtVA ¼ 0·28, Dt12 ¼ 0·56;% FAME) were greater than the increase from 7 d to 42 d (DtVA ¼ 0·17, Dt12 ¼ 0·21;% FAME). The control group serum levels of tVA, t12, and c9,t11 CLA after 42 d remained unchanged throughout the intervention and were significantly lower that those of the test group (P#0·005; Table 3 ). The slope of the linear regression of Dc9,t11 CLA v. the sum of DtVA and Dc9,t11 CLA in the serum lipids of the test group after 7 d (P¼0·001) and 42 d (P¼0·001) of intervention represents the percentage conversion (Fig. 2) . The mean conversion rate of tVA after 7 d and 42 d was 24 (SD 10) % and 25 (SD 9) %, respectively. After 7 d of intervention, men showed a lower conversion rate (15 (SD 8) %) than women (31 (SD 6) %; P¼0·004). In contrast, after 42 d of intervention, the conversion rates of both genders were identical (men 23 (SD 6) %, women 26 (SD 11) %; P¼0·537).
After 7 and 42 d, all test-group subjects showed an increase in tVA in their serum lipids. Subjects in the test group demonstrated a highly individualistic conversion of tVA to c9,t11 CLA. Thus, the conversion rate of serum tVA ranged from 5 % to 37 % (7 d) and from 14 % to 40 % (42 d). Some subjects showed an higher conversion rate initially than after 42 d of intervention, and vice versa. The highest intra-individual range of conversion rate was from 5 % (7 d) to 28 % (42 d). One test-group subject showed no increase in c9,t11 CLA after 42 d compared with the adaptation period. Thus, no conversion of tVA in the serum was verified ('non-responder'). In general, no conversion of t12 to c9t12-18 : 2 was determined in test-group serum samples at both times (7 d, 42 d) .
Analysis of the distribution of CLA isomers showed that the major CLA isomer in the serum was c9,t11 CLA (76 (SD 4) % of total CLA in the adaptation period). During the intervention, serum c9,t11 CLA levels in the test group increased to 79 (SD 5) % and 84 (SD 5) % of total CLA after 7 d and 42 d, respectively (P¼0·136, P¼0·034). In contrast, after 42 d, the c9,t11 CLA levels of the control group decreased to 72 (SD 4) % of total CLA (P¼0·010) and were significantly lower than those found in the test group (P¼0·002).
Red blood cell membranes
RBCM lipids were not determined after 7 d of the intervention period because no detectable incorporation of c9,t11 CLA into the membranes was expected. The fatty acid distribution of RBCM lipids did not differ between men and women in the two groups. In the test group, RBCM tVA levels increased significantly by fivefold (P ¼ 0·002), and t12 levels increased significantly by ninefold (P¼0·002) after 42 d compared with the adaptation period (Table 3 ). In addition, the test-group c9,t11 CLA levels in the RBCM increased significantly from 0·15 % to 0·18 % of total FAME (P¼0·021), whereas no change in c9,t12-18 : 2 was observed (Table 3 ). In one testgroup subject, the c9,t11 CLA level in the RBCM decreased by approximately half of its adaptation period value over the 42 d intervention despite a large increase of tVA in the RBCM. In addition, the increase in tVA in this subject was about 30 % higher than that of the other test-group subjects. This so-called non-responder was excluded from the mean calculations of serum and RBCM lipid analysis in the test group (therefore n 11). After the 42 d intervention period, the control group showed a significant lowering of c9,t11 CLA by ,50 % (D 0·07 % FAME) compared with the adaptation period (P# 0·01), whereas levels of t11, t12 and c9,t12-18 : 2 were unchanged ( Table 3 ). Assuming that, without tVA supplementation, the c9,t11 CLA levels of test-group RBCM would be decreased as in control subjects, the mean Dc9,t11 CLA of controlgroup RBCM after 42 d (0·07) was included as a correction factor in equation 2 for each test-group subject (equation 3)
To estimate the average of conversion of tVA in the test group, a linear regression was performed, which showed a linear trend (y ¼ 0·234x-0·003; P¼0·066). The calculated conversion rate of tVA to c9,t11 CLA of the test group was in 19 (SD 3) % (equation 3). The conversion rate estimated from the RBCM ranged from 15 % to 25 %. In these data, the correction factor was, however, included for each testgroup subject so the range is not representative. After the adaptation period, the c9,t11 isomer represented 78 (SD 4) % of total CLA of RBCM. After 42 d of intervention for the test group, only the c9,t11 isomer was increased to 83 (SD 7) % of total CLA, whereas in the control group it was reduced to 75 (SD 7) % and was significantly lower than that of the test group (P¼0·029).
Discussion
The D9-desaturase -an enzyme that desaturates saturated fatty acid to MUFA (e.g. stearic to oleic acid) -of rat liver microsomes converted tVA to c9,t11 CLA and t12 to c9,t12-18 : 2 (Mahfouz et al. 1980; Pollard et al. 1980; Holman & Mahfouz, 1981) . The present study demonstrated that dietary tVA was effectively D9-desaturated compared with t12. Increased tVA concentrations in serum as well as in RBCM were associated with increased c9,t11 CLA concentrations in serum and RBCM (Table 3) .
Previous studies in animals observed the conversion of dietary tVA to CLA and its accumulation in different body tissues (Ip et al. 1999; Gläser et al. 2000; Santora et al. 2000; Banni et al. 2001; Loor et al. 2002; Kraft, 2004) . Furthermore, studies in humans have also described an increase in c9,t11 CLA levels when tVA was supplemented (Salminen et al. 1998; Adlof et al. 2000; Turpeinen et al. 2002;  Table 4) . Turpeinen et al. (2002) used the same fatty acid preparation as in previous studies with different dosages (1·5 g, 3·0 g and 4·5 g tVA/d, respectively) during a 9 d trial period. We conducted a study over the longer period of 42 d to determine the conversion rate after a long-term intervention and to investigate the incorporation of supplemented trans-18 : 1 isomers into tissues such as RBCM. Furthermore, to in order estimate the conversion rate after short-term intervention and compare the results with those of Turpeinen et al. (2002) , blood samples were collected after 7 d. Turpeinen et al. (2002) observed similar short-term results, producing a 307 % increase in serum tVA level from a dietary intake of 3·0 g tVA/d (corresponding value in the present study, 400 %; Table 3 ). At a dosage of 4·5 g tVA/d, serum tVA increased after 9 d by about 620 %, which is similar to the value seen when 3·0 g dietary tVA/d was given over a 42 d period (643 %, Table 3 ). The increase in serum tVA was related with an increase in c9,t11 CLA in the serum lipids in both this and Turpeinen's studies ( Fig. 2 ; see also Turpeinen et al. 2002) . The conversion rate of serum tVA determined by Turpeinen et al. (2002) was on average 19 %. In our preliminary study (unpublished results; study conducted under the same conditions) with women who consumed 1·2 g tVA daily over 28 d,
∆tVA + c9,t11 CLA Fig. 2 . Linear regression between the net change in c9,t11 conjugated linoleic acid (CLA (Dc9,t11 CLA) and trans-vaccenic acid (DtVA) þ Dc9,t11 conjugated linoleic acid (CLA) in the serum lipids of the test group after 7 d (A) and 42 d (B) of intervention. The slope represents the average conversion of tVA. X, female subjects; V, male subjects. elevated serum c9,t11 CLA levels were observed as well. The conversion rate was also about 20 % (Table 4 ). The conversion rates obtained in these studies are consistent with that obtained (25 %) after 42 d with 3·0 g tVA (Table 4) . This calculation of the conversion rate was only an estimation approximately how much of the supplemented tVA and t12 was converted to c9,t11 CLA and c9,t12-18 : 2, respectively by D9-desaturation. This calculation is only a net end-product estimation. The ratio of the change in tVA and c9,t11 CLA, and in t12 and c9,t12-18 : 2, respectively, relative to the adaptation period do not reflect their real gross conversion rate but the net sum of their surviving products. These estimates of conversion rate are influenced by several metabolic processes (e.g. ß-oxidation, elongation) and by incorporation into the specific tissue lipids. It is difficult to incorporate the oxidation rates of the supplemented fatty acids and their desaturation products to the calculation of conversion in humans. Sergiel et al. (2001) showed, in rats, that c9,t11 CLA was oxidized significantly more than linoleic acid. Thus, the real levels of c9,t11 CLA synthesized from tVA are probably higher.
It appears that CLA formed by the endogenous desaturation of tVA is incorporated primarily into neutral lipids and secondarily into various classes of phospholipids (Banni et al. 2001) . The increase in c9,t11 CLA in the RBCM was greater than that of t10,c12 CLA, suggesting that the extent of incorporation of individual CLA isomers may be tissue dependent (Burdge et al. 2005) . Kraft (2004) showed the highest accumulation of endogenously synthesized CLA in tissues rich in neutral lipids, for example, adipose tissue, followed by the gonads, thymus, kidney, muscle, liver, etc. The conversion rate thus differed between different pools and organs (e.g. serum 22 %, muscle 20 %, liver 17 %; Kraft, 2004) and might depend on the content of phospholipids and neutral lipids and on tissuespecific metabolic rates, that of heart, for example, being 8 %.
Serum levels reflect only the dietary intake of the previous few days (Kohlmeier, 1995) . RBCM provide a marker reflecting a longer-term intake and offer a more aggregated time period than serum (Arab, 2003) . Human RBC have a mean lifetime of about 120 d (Loeffler, 2005) and their membranes reflect the intake over this lifespan (Arab, 2003) . We therefore used the RBCM as a low-invasion method to analyse the incorporation of fatty acids during this study, with the assumption that approximately one third of RBC were renewed after the intervention period (42 d).
The RBCM of pigs fed CLA (Stangl et al. 1999 ) and of rats fed tVA (Kraft, 2004) showed a linear increase in c9,t11 CLA. Obviously, dietary tVA and t12 as well as endogenously synthesized c9,t11 CLA were incorporated into test-group RBCM after 42 d (Table 3) . Fatty acid analysis of the RBCM revealed a decrease in c9,t11 CLA in the control group (Table 3) . These results indicated clearly that the diet supplied was poor in trans-fatty acids and CLA, and that these subjects had complied with the required study diet. In addition, this decrease in c9,t11 CLA could be included in calculations of the conversion rate of incorporated fatty acids and was able to produce an improved estimation of the tVA conversion rate, which was 19 (SD 3) %. The relation between the mean content of tVA and c9,t11 CLA in the test-group RBCM after 42 d and that in the control group after 42 d resulted in a tVA conversion rate of approximately 23 %. Both methods corroborate the tVA conversion rate estimated using serum.
Furthermore, the conversion rate in rats calculated by the net changes in serum tVA and CLA was 22 %, which was nearly equivalent to the whole-body conversion rate in the rat (25 %, mean of all tissue conversion rates; Kraft, 2004) . These results suggest that the tVA conversion rate estimated by human serum is also representative of that for the whole human body.
In general, the conversion rate of tVA estimated from the serum showed a wide range within subjects and between times of intervention (7 d, 42 d). Turpeinen et al. (2002) also found interindividual differences in the conversion rate of serum tVA (e.g. non-responder, low-responder). Furthermore, after 7 d of intervention in the present study, women showed a higher tVA conversion rate than men, whereas after 42 d no difference was observed.
First, the diet at the time of blood collection at day 7 was not the standardized diet and was not similarly controlled. The differences in conversion rate between 7 d and 42 d of intervention (gender specific and intra-individual) could be partly explained by dietary factors in the individual diets. Dietary factors such as cholesterol, PUFA, carbohydrates and vitamin A have been shown to affect the D9-desaturase activity in mammals (Ntambi, 1992; Miller et al. 1997; Sessler & Ntambi, 1998; Tocher et al. 1998; Ntambi, 1999; Ntambi, 2004) . However, the desaturation indices differ between treatment groups, genders and blood collection times (0 d, 7 d, 42 d; data not shown). Second, it is conceivable that there are gene polymorphisms of D9-desaturase (also described for other enzymes of lipid metabolism; e.g., Halsall et al. 2000; Galluzzi et al. 2001; Talmud et al. 2001 ) that may determine gene expression, enzyme activity or substrate specificity. The conversion rate estimated from the serum could be more dependent on individual differences in fatty acid metabolism (differences in enzyme activities and saturations, abundance of cellular signalling transduction elements and substrate kinetics; Mittendorfer et al. 2005) . These facts might also explain the observed interindividual differences in conversion rate and the findings in the nonresponder. In addition, gender-specific differences in the expression of D9-desaturase were observed in mice (Lee et al. 1996) and could be partly related to hormones (Tocher et al. 1998; Miyazaki et al. 2003; Cohen & Friedman, 2004) or to body fat mass (Legrand & Hermier, 1992; Jones et al. 1996) .
In the present study, the non-responder (with no conversion of the supplemented tVA) identified on RBCM analysis was excluded from the data analysis. The inclusion of this subject's data in the conversion rate calculation does not seriously change the mean conversion rates (serum 24 (SD 10) %, 7 d, 23 (SD 11) %, 42 d; RBCM 18 (SD 6) %).
Altogether, serum lipids are adequate to estimate the conversion rate of tVA, especially after a short-term intervention, whereas RBCM lipids were better for estimating the conversion rate of tVA into incorporated fatty acid after a longer intervention period. The conversion rates estimated by serum and RBCM were similar and ranged on average from 19 % to 25 %.
Despite an increase in t12 in lipids in the serum and RBCM of the test group, no significant increase in c9,t12-18 : 2 concentration was observed (Table 3) . Thus, no conversion of supplemented t12 could be assessed via serum and RBCM samples. In other studies, Salminen et al. (1998) did not analyse any individual trans-18 : 1 isomers, and Turpeinen et al. (2002) gave no detailed information on serum t12 and c9,t12-18 : 2 levels. In cows receiving an abomasal infusion of a mixture of tVA and t12, these fatty acids and their desaturation products c9,t11 CLA and c9,t12-18 : 2 were incorporated into milk fat (Griinari et al. 2000) . The increases in t12 and c9,t12-18 : 2 level (64 %) were higher than the increases in tVA and c9,t11 CLA level (40 %), whereas a higher conversion rate was observed for tVA (31 %) than t12 (10 %; Griinari et al. 2000) . In rats fed tVA and t12, the conversion rate of tVA was also substantially higher than the conversion rate of t12 (Kraft, 2004) . In the present study, the mean increase in t12 level was generally 30 % higher than the mean increase in tVA level (including ,22 % converted tVA) in both serum and RBCM. The greater increase in t12 levels is approved by the literature (Griinari et al. 2000; Kraft, 2004) , and, in general, tVA, compared with t12, is preferentially metabolized by desaturation, especially D9, elongation and b-oxidation. Furthermore, there are different rates of activation to their CoA-esters before desaturation (Lippel 1973) .
The consumption of trans-fatty acids and their effects on human health is still under review (European Food Safety Authority, 2004; Weggemans et al. 2004 , Lock et al. 2005 . The most important factor to consider when comparing tVA with other trans-18 : 1 isomers is that tVA is readily converted to c9,t11 CLA. Further research is required into the mechanisms of tVA desaturation and the effects of individual trans-18 : 1 isomers on human health.
We can conclude from the present study that tVA was effectively D9-desaturated to c9,t11 CLA, whereas a conversion of t12 to c9,t12-18 : 2 could not be detected. The average conversion rate of tVA in serum was 24 %, and the value from fatty acids incorporated into RBCM was 19 %. The conversion of tVA to c9,t11 CLA (20-25 %) should be taken into account in future studies when determining the CLA supply.
